Skip to main content
An official website of the United States government
Email

EU-U.S. Cancer Health Cooperation Working Group

In the ongoing fight against cancer, cooperation emerges as the cornerstone. Recognizing this imperative, the European Union (EU) and the United States (U.S.) jointly launched the EU-U.S. Health Task Force in May 2023 (Joint Press Release). This trans-Atlantic Task Force aims to bolster the partnership between the EU and the U.S. in the realm of health, concentrating on three main areas:

  • Prioritizing cancer
  • Addressing global health threats
  • Fortifying the global health infrastructure

Expert Level Working Groups

Within the framework of this collaboration, the EU-U.S. Cancer Health Cooperation Expert-level Working Groups have been established. Both the EU and the U.S. are committed to enhancing cancer prevention, detection, and treatment for all individuals affected by the disease. The focus areas include:

  • Pediatric and young adult rare cancers
  • Adult cancer screening and treatment, with an initial emphasis on lung cancer.

Additionally, there is a strong determination to overcome barriers hindering the sharing of data resources. This thereby expedites advancements in health research.

Objectives and Initiatives

The overarching goal is to establish a structured dialogue on cancer, encompassing both policy and research collaborations. This entails harmonizing the U.S. Cancer Moonshot Initiative with Europe’s Beating Cancer Plan, the EU Cancer Mission, and the U.S. National Cancer Plan, thereby driving forward collective progress in combating cancer.

To achieve these objectives, the Task Force has formed two expert-level working groups dedicated to

  • Childhood/young adult cancer
  • Lung cancer

These groups align with Europe’s Beating Cancer Plan and the U.S. Cancer Moonshot initiative. Their collaborative efforts aim to:

  • Foster peer-learning
  • Exchange best practices
  • Provide guidance on potential joint initiatives to enhance cancer outcomes globally

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “EU-U.S. Cancer Health Cooperation Working Group was originally published by the National Cancer Institute.”

Email